MTOR and acute promyelocytic leukemia: (197) demonstrated that arsenic trioxide (ATO) increased the formation of extracellular traps by acute promyelocytic leukemia (APL) cells through mammalian target of rapamycin (mTOR)-dependent autophagy, which was partially regulated by ROS.